BIOCRYST PHARMACEUTICALS INC

Ticker: BCRX CUSIP: 09058V103 Class: Common Stock

EAM Investors, LLC's Holding History (CIK: 0001510989)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 334,347 Value ($000) $2,996 Avg Close $9.31 Range $6.02 - $11.31

Q1 2022

Shares 162,969 Value ($000) $2,650 Avg Close $16.04 Range $11.56 - $19.99

Q3 2021

Shares 163,324 Value ($000) $2,347 Avg Close $15.77 Range $14.00 - $18.48

Q2 2021

Shares 249,856 Value ($000) $3,950 Avg Close $13.59 Range $9.23 - $17.74

Q2 2020

Shares 563,961 Value ($000) $2,687 Avg Close $3.99 Range $1.80 - $6.29

Q1 2019

Shares 287,805 Value ($000) $2,343 Avg Close $8.56 Range $7.10 - $9.95

Q4 2018

Shares 304,277 Value ($000) $2,456 Avg Close $7.78 Range $6.43 - $9.71

Q1 2017

Shares 109,625 Value ($000) $921 Avg Close $6.96 Range $4.20 - $9.25

Q3 2015

Shares 89,061 Value ($000) $1,015 Avg Close $13.34 Range $10.26 - $16.83

Q2 2015

Shares 116,969 Value ($000) $1,746 Avg Close $11.37 Range $8.50 - $16.43

Q3 2014

Shares 85,721 Value ($000) $838 Avg Close $12.26 Range $9.78 - $14.62

Q2 2014

Shares 85,721 Value ($000) $1,093 Avg Close $9.73 Range $7.29 - $12.86

Q1 2014

Shares 114,548 Value ($000) $1,212 Avg Close $10.66 Range $7.46 - $13.33

Q3 2013

Shares 148,081 Value ($000) $1,078 Avg Close $5.07 Range $1.51 - $7.59

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	334,347	$2,996	$9.31	$6.02 - $11.31
Q1 2022	162,969	$2,650	$16.04	$11.56 - $19.99
Q3 2021	163,324	$2,347	$15.77	$14.00 - $18.48
Q2 2021	249,856	$3,950	$13.59	$9.23 - $17.74
Q2 2020	563,961	$2,687	$3.99	$1.80 - $6.29
Q1 2019	287,805	$2,343	$8.56	$7.10 - $9.95
Q4 2018	304,277	$2,456	$7.78	$6.43 - $9.71
Q1 2017	109,625	$921	$6.96	$4.20 - $9.25
Q3 2015	89,061	$1,015	$13.34	$10.26 - $16.83
Q2 2015	116,969	$1,746	$11.37	$8.50 - $16.43
Q3 2014	85,721	$838	$12.26	$9.78 - $14.62
Q2 2014	85,721	$1,093	$9.73	$7.29 - $12.86
Q1 2014	114,548	$1,212	$10.66	$7.46 - $13.33
Q3 2013	148,081	$1,078	$5.07	$1.51 - $7.59